Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Hubbert

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Virology|July 1, 1992
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activityS A Sedman, N L Hubbert, W C Vass, et al.
American Journal of Veterinary Research|February 1, 1983
Serum proteins in healthy Basenjis and Basenjis with chronic diarrheaE B Breitschwerdt, O Barta, C Waltman, et al.
Journal of Virology|August 1, 1995
Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptorR B Roden, N L Hubbert, R Kirnbauer, et al.
Journal of Virology|May 1, 1996
Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibitionR B Roden, N L Hubbert, R Kirnbauer, et al.
Journal of the National Cancer Institute|April 6, 1994
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16R Kirnbauer, N L Hubbert, C M Wheeler, et al.
Journal of Virology|June 1, 1995
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infectionF Breitburd, R Kirnbauer, N L Hubbert, et al.
Journal of Virology|September 1, 1991
The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in cultureS A Sedman, M S Barbosa, W C Vass, et al.
Journal of Virology|August 1, 1997
Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitopeR B Roden, A Armstrong, P Haderer, et al.
Journal of the National Cancer Institute|October 16, 1996
Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, ChinaC Han, G Qiao, N L Hubbert, et al.
The Journal of Infectious Diseases|July 1, 1995
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and SpainB Nonnenmacher, N L Hubbert, R Kirnbauer, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Virology|July 1, 1992
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activityS A Sedman, N L Hubbert, W C Vass, et al.
American Journal of Veterinary Research|February 1, 1983
Serum proteins in healthy Basenjis and Basenjis with chronic diarrheaE B Breitschwerdt, O Barta, C Waltman, et al.
Journal of Virology|August 1, 1995
Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptorR B Roden, N L Hubbert, R Kirnbauer, et al.
Journal of Virology|May 1, 1996
Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibitionR B Roden, N L Hubbert, R Kirnbauer, et al.
Journal of the National Cancer Institute|April 6, 1994
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16R Kirnbauer, N L Hubbert, C M Wheeler, et al.
Journal of Virology|June 1, 1995
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infectionF Breitburd, R Kirnbauer, N L Hubbert, et al.
Journal of Virology|September 1, 1991
The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in cultureS A Sedman, M S Barbosa, W C Vass, et al.
Journal of Virology|August 1, 1997
Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitopeR B Roden, A Armstrong, P Haderer, et al.
Journal of the National Cancer Institute|October 16, 1996
Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, ChinaC Han, G Qiao, N L Hubbert, et al.
The Journal of Infectious Diseases|July 1, 1995
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and SpainB Nonnenmacher, N L Hubbert, R Kirnbauer, et al.
Pageof 3